Author:
Torres Harrys A.,Davila Marta
Publisher
Springer Science and Business Media LLC
Reference101 articles.
1. Torres, H. A., Boeckh, M. & Chemaly, R. F. in Medical Care of Cancer Patients (eds Yeung, S. J., Escalante, C. & Gagel, R. F.) 151–161 (B. C. Decker Inc Publisher, Shelton, CT, 2009).
2. Lok, A. S. et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 100, 182–188 (1991).
3. Law, J. K. et al. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk. Lymphoma 46, 1085–1089 (2005).
4. Alexopoulos, C. G., Vaslamatzis, M. & Hatzidimitriou, G. Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours. Br. J. Cancer 81, 69–74 (1999).
5. Yeo, W. et al. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. J. Clin. Oncol. 22, 927–934 (2004).
Cited by
144 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献